Panagene Inc
Panagene Inc. develops products in the field of molecular diagnostics in South Korea. Its products include Liquid biopsy products for lung and colon cancers; tissue biopsy products for lung, thyroid, pancreatic, and colon cancers, as well as glioblastoma, myeloproliferative neoplasm, chronic myelogenous leukemia, central nervous system, myelofibrosis, and polycythemia vera diseases. The company a… Read more
Market Cap & Net Worth: Panagene Inc (046210)
Panagene Inc (KQ:046210) has a market capitalization of $49.38 Million (₩72.31 Billion) as of March 18, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #23608 globally and #1292 in its home market, demonstrating a 17.92% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Panagene Inc's stock price ₩2250.00 by its total outstanding shares 32136700 (32.14 Million).
Panagene Inc Market Cap History: 2015 to 2026
Panagene Inc's market capitalization history from 2015 to 2026. Data shows change from $98.55 Million to $49.38 Million (-6.69% CAGR).
Index Memberships
Panagene Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$167.85 Billion | 0.02% | #636 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$167.85 Billion | 0.02% | #636 of 1384 |
Weight: Panagene Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Panagene Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Panagene Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Panagene Inc's market cap is 0.00 times its annual revenue
0.16x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $98.55 Million | $5.92 Billion | -$629.74 Million | 0.02x | N/A |
| 2016 | $149.69 Million | $6.96 Billion | -$1.56 Billion | 0.02x | N/A |
| 2017 | $186.12 Million | $7.39 Billion | -$6.96 Billion | 0.03x | N/A |
| 2018 | $99.75 Million | $7.70 Billion | -$4.12 Billion | 0.01x | N/A |
| 2019 | $51.47 Million | $7.95 Billion | $3.50 Billion | 0.01x | 0.01x |
| 2020 | $94.49 Million | $16.27 Billion | $4.92 Billion | 0.01x | 0.02x |
| 2021 | $83.29 Million | $15.60 Billion | $4.97 Billion | 0.01x | 0.02x |
| 2022 | $93.06 Million | $14.17 Billion | $2.24 Billion | 0.01x | 0.04x |
| 2023 | $90.65 Million | $12.25 Billion | -$4.82 Billion | 0.01x | N/A |
| 2024 | $61.89 Million | $13.20 Billion | -$1.94 Billion | 0.00x | N/A |
Competitor Companies of 046210 by Market Capitalization
Companies near Panagene Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Panagene Inc by market ranking:
- Peptron Inc (KQ:087010): Ranked #3322 globally with a market cap of $3.92 Billion USD ( ₩5.74 Trillion KRW).
- MEDIPOST Co. Ltd (KQ:078160): Ranked #15247 globally with a market cap of $192.41 Million USD ( ₩281.72 Billion KRW).
- Cell Biotech Co. Ltd (KQ:049960): Ranked #21924 globally with a market cap of $43.10 Million USD ( ₩63.11 Billion KRW).
- Biotoxtech Co. Ltd (KQ:086040): Ranked #24783 globally with a market cap of $23.35 Million USD ( ₩34.19 Billion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #3322 | Peptron Inc | KQ:087010 | $3.92 Billion | ₩311000.00 |
| #15247 | MEDIPOST Co. Ltd | KQ:078160 | $192.41 Million | ₩22200.00 |
| #21924 | Cell Biotech Co. Ltd | KQ:049960 | $43.10 Million | ₩14070.00 |
| #24783 | Biotoxtech Co. Ltd | KQ:086040 | $23.35 Million | ₩3200.00 |
Panagene Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Panagene Inc's market cap moved from $98.55 Million to $ 49.38 Million, with a yearly change of -6.69%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩49.38 Million | +29.61% |
| 2025 | ₩38.10 Million | -38.44% |
| 2024 | ₩61.89 Million | -31.72% |
| 2023 | ₩90.65 Million | -2.59% |
| 2022 | ₩93.06 Million | +11.73% |
| 2021 | ₩83.29 Million | -11.85% |
| 2020 | ₩94.49 Million | +83.58% |
| 2019 | ₩51.47 Million | -48.40% |
| 2018 | ₩99.75 Million | -46.40% |
| 2017 | ₩186.12 Million | +24.34% |
| 2016 | ₩149.69 Million | +51.89% |
| 2015 | ₩98.55 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Panagene Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $49.38 Million USD |
| MoneyControl | $49.38 Million USD |
| MarketWatch | $49.38 Million USD |
| marketcap.company | $49.38 Million USD |
| Reuters | $49.38 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.